Understanding the complexities of MRI-targeted biopsies

A recent video-discussion on the OncLive web site addresses the complexities in the evolution of application of multiparametric MRI scanning and MRI/TRUS fusion biopsies in the diagnosis of early stage prostate cancers. … READ MORE …

Intervew with three leading researchers at the NCI

Many readers may be interested in having a look at the text based on a recent interview carried out with four clinicians who specialize in research into the management of prostate cancer at the National Cancer Institute (NCI) and the NCI Clinical Center in Bethesda, Maryland. … READ MORE …

In-office MRI/TRUS fusion imaging and prostate biopsies

Readers interested on a the potential future of office-based prostate cancer imaging (for the conduct of biopsies and perhaps for other purposes too) may be interested in an article published today on the HealthDay web site. … READ MORE …

CE-TRUS-targeted vs. systematic, TRUS-guided biopsy of the prostate to diagnose prostate cancer

Contrast-enhanced, transrectal ultrasound (CE-TRUS) technology has been found to better detect high-grade prostate cancer than conventional forms of TRUS, which may make it a more appropriate method for the diagnosis of clinically important cancers and monitoring low-risk ones with less biopsies. … READ MORE …

The accuracy (and value) of MRI methods in diagnosis and prognosis of prostate cancer

Two recent studies are helpful in clarifying the issue of when specific types of magnetic resonance imaging (MRI) meothds may be useful in the diagnosis and prognosis of prostate cancer. … READ MORE …

Transrectal ultrasound: impact on clinical staging

New data just published by a group at the University of California, San Francisco (UCSF) suggests that, in the current era, transrectal ultrasound (TRUS) provides an accurate means to assess the clinical (pre-treatment) stage of a man’s prostate cancer. … READ MORE …